Buys
Open market- Shares
- Avg price
- Total value
Amos Bar-Shalev - Director at Protalix BioTherapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PLX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Amos Bar-Shalev in Protalix BioTherapeutics, Inc.
Sells
Open market- Shares
- -168
- Avg price
- $1.87
- Total value
- -$314
Net
Past year- Shares
- -168
- Share %
- -100%
- Total value
- -$314
Reported holdings for Amos Bar-Shalev in Protalix BioTherapeutics, Inc.
Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,500
- Estimated value
- $16,950
- Report date
- 18 Nov 2025
- Price
- $2.26
- Ownership
- By Trust
Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 18 Nov 2025
- Price
- $1.87
- Ownership
- Direct
Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 17,000
- Estimated value
- Report date
- 03 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Protalix BioTherapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 8,500
- Estimated value
- Report date
- 03 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Amos Bar-Shalev in Protalix BioTherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.